FOREST LABORATORIES HOLDINGS LIMITED

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 39216
 
  
 
C07D HETEROCYCLIC COMPOUNDS 20142
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 689
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 5133
 
  
 
C07K PEPTIDES 3133
 
  
 
A01M CATCHING, TRAPPING OR SCARING OF ANIMALS 121
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 1153
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0172,942 ORALLY DISSOLVING FORMULATIONS OF MEMANTINEMar 06, 17Jun 22, 17[A61K]
2016/0310,559 Delayed Release Compositions of LinaclotideDec 11, 14Oct 27, 16[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9695122 Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereofFeb 10, 16Jul 04, 17[A61K, C07D]
9629861 Compositions and methods for treating bacterial infections using ceftarolineMay 27, 15Apr 25, 17[A61K]
9580424 Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium saltMay 13, 15Feb 28, 17[A61K, C07D]
9283261 Linaclotide compositionsSep 18, 14Mar 15, 16[A61K, C07K]
9284314 Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereofJan 05, 15Mar 15, 16[C07D]
9259403 Crystalline forms of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamideOct 20, 14Feb 16, 16[A61K, A01N, C07C]
9221821 Methods for the synthesis of 1,3-substituted aminouracils and other xanthine-related compoundsMay 31, 13Dec 29, 15[C07D]
9062053 Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-Diazabicyclo[3,2,1]octane-2-carboxamide sodium saltAug 07, 14Jun 23, 15[A61K, C07D]
8969566 Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereofFeb 14, 14Mar 03, 15[C07D]
8912197 Crystalline form of carbamoyl-cyclohexane derivativesMar 14, 13Dec 16, 14[A61K, C07D, C07C]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0281,722 Treatment of Constipation-Predominant Irritable Bowel SyndromeAbandonedJun 16, 17Oct 05, 17[A61K]
2016/0206,686 Treatment of Constipation-Predominant Irritable Bowel SyndromeAbandonedMar 31, 16Jul 21, 16[A61K]
2015/0374,673 Combination Therapy for the Treatment of Nosocomial PneumoniaAbandonedFeb 06, 14Dec 31, 15[A61K]
2015/0196,572 SOLUBLE DOSAGE FORMS CONTAINING CEPHEM DERIVATIVES SUITABLE FOR PARENTERAL ADMINISTRATIONAbandonedMar 04, 15Jul 16, 15[A61K]
2015/0031,632 Orally Disintegrating Compositions of LinaclotideAbandonedOct 09, 14Jan 29, 15[A61K, C07K]
2014/0378,393 Stable Formulations of LinaclotideAbandonedSep 12, 14Dec 25, 14[A61K]
2014/0349,948 Treatment of Chronic ConstipationAbandonedDec 23, 13Nov 27, 14[A61K]
2014/0287,034 Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral AdministrationAbandonedMay 23, 14Sep 25, 14[A61K, G01N]
2014/0213,659 MODIFIED RELEASE FORMULATIONS OF MEMANTINE ORAL DOSAGE FORMSAbandonedMar 28, 14Jul 31, 14[A61K]
2014/0162,963 Treatment of Constipation-Predominant Irritable Bowel SyndromeAbandonedSep 09, 11Jun 12, 14[A61K]
2014/0154,322 FOR INJECTABLE FORMULATIONS CONTAINING ASENAPINE AND METHOD OF TREATMENT USING SAMEAbandonedDec 17, 13Jun 05, 14[A61K]
2014/0057,954 CHEMICAL COMPOSITIONAbandonedMar 14, 13Feb 27, 14[A61K]
2014/0023,710 MILNACIPRAN FORMULATIONSAbandonedSep 16, 13Jan 23, 14[A61K]
2014/0018,307 LINACLOTIDE COMPOSITIONSAbandonedMar 13, 13Jan 16, 14[C07K]
2013/0310,460 MODIFIED RELEASE FORMULATIONS OF MEMANTINE ORAL DOSAGE FORMSAbandonedJul 23, 13Nov 21, 13[A61K]
2013/0253,063 STABLE DOSAGE FORMS OF LEVOMILNACIPRANAbandonedApr 02, 13Sep 26, 13[C07C]
2013/0190,239 Formulations Comprising LinaclotideAbandonedMar 15, 13Jul 25, 13[A61K]
2013/0172,303 ROFLUMILAST COMPOSITIONS FOR THE TREATMENT OF COPDAbandonedJan 03, 13Jul 04, 13[A61K]
2013/0109,646 METHOD FOR TREATING GLAUCOMA OR OCULAR HYPERTENSION WITH AN ADENOSINE DERIVATIVEAbandonedDec 20, 12May 02, 13[A61K]
2013/0011,474 MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINEAbandonedSep 14, 12Jan 10, 13[A61K, C07C, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.